Prothrombotic Responses After Catheter Ablation for Atrial Fibrillation During Uninterrupted Oral Anticoagulant Agent Administration

Calkins, 2017, 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation, Heart Rhythm, 14, e275, 10.1016/j.hrthm.2017.05.012

Liu, 2016, Incidence and outcomes of cerebrovascular events complicating catheter ablation for atrial fibrillation, Europace, 18, 1357, 10.1093/europace/euv356

Oral, 2006, Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation, Circulation, 114, 759, 10.1161/CIRCULATIONAHA.106.641225

Kirchhof, 2018, Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation, Eur Heart J, 39, 2942, 10.1093/eurheartj/ehy176

Calkins, 2017, Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation, N Engl J Med, 376, 1627, 10.1056/NEJMoa1701005

Cappato, 2015, Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation, Eur Heart J, 36, 1805, 10.1093/eurheartj/ehv177

Kimura, 2018, Asymptomatic cerebral infarction during catheter ablation for atrial fibrillation: comparing uninterrupted rivaroxaban and warfarin (ASCERTAIN), J Am Coll Cardiol EP, 4, 1598

Manolis, 1996, Thrombogenicity of radiofrequency lesions: results with serial d-dimer determinations, J Am Coll Cardiol, 28, 1257, 10.1016/S0735-1097(96)00324-5

Hisazaki, 2019, Endothelial damage and thromboembolic risk after pulmonary vein isolation using the latest ablation technologies: a comparison of the second-generation cryoballoon vs. contact force-sensing radiofrequency ablation, Heart Vessels, 34, 509, 10.1007/s00380-018-1257-7

Tao, 2017, Efficacy and safety of uninterrupted rivaroxaban taken preoperatively for radiofrequency catheter ablation of atrial fibrillation compared to uninterrupted warfarin, J Interv Card Electrophysiol, 48, 167, 10.1007/s10840-016-0214-6

Brendel, 2017, The anticoagulant effect of heparin during radiofrequency ablation (RFA) in patients taking apixaban or rivaroxaban, J Interv Card Electrophysiol, 49, 237, 10.1007/s10840-017-0274-2

Otuki, 2018, Effects of direct oral anticoagulants at the peak phase, trough phase, and after vascular injury, J Am Coll Cardiol, 71, 102, 10.1016/j.jacc.2017.10.076

2014, Guidelines for pharmacotherapy of atrial fibrillation (JCS 2013), Circ J, 78, 1997, 10.1253/circj.CJ-66-0092

Yanagisawa, 2018, Renal function and risk of stroke and bleeding in patients undergoing catheter ablation for atrial fibrillation: comparison between uninterrupted direct oral anticoagulants and warfarin administration, Heart Rhythm, 15, 348, 10.1016/j.hrthm.2017.10.033

Khairy, 2003, Lower incidence of thrombus formation with cryoenergy versus radiofrequency catheter ablation, Circulation, 107, 2045, 10.1161/01.CIR.0000058706.82623.A1

Nagy-Balo, 2013, Transcranial measurement of cerebral microembolic signals during pulmonary vein isolation: a comparison of two ablation techniques, Circ Arrhythm Electrophysiol, 6, 473, 10.1161/CIRCEP.112.971747

Christersson, 2014, d-Dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation—observations from the ARISTOTLE trial, J Thromb Haemost, 12, 1401, 10.1111/jth.12638

Wissner, 2014, Asymptomatic brain lesions following laserballoon-based pulmonary vein isolation, Europace, 16, 214, 10.1093/europace/eut250

Martinek, 2013, Asymptomatic cerebral lesions during pulmonary vein isolation under uninterrupted oral anticoagulation, Europace, 15, 325, 10.1093/europace/eus329

Christersson, 2019, Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation, Heart, 105, 235, 10.1136/heartjnl-2018-313351

Hagii, 2016, Effect of rivaroxaban on prothrombin fragment 1+2 compared with warfarin in patients with acute cardioembolic stroke: Insight from its serial measurement, Thromb Res, 148, 9, 10.1016/j.thromres.2016.10.011